相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Expression and Clinical Significance of STAT3, P-STAT3, and VEGF-C in Small Cell Lung Cancer
Xue Zhao et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
JAK2-related pathway induces acquired erlotinib resistance in lung cancer cells harboring an epidermal growth factor receptor-activating mutation
Daijiro Harada et al.
CANCER SCIENCE (2012)
Genomic Landscape of Non-Small Cell Lung Cancer in Smokers and Never-Smokers
Ramaswamy Govindan et al.
CELL (2012)
JAK/STAT signal pathway activation promotes progression and survival of human oesophageal squamous cell carcinoma
Zhenbing You et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2012)
Let-7 Expression Is a Significant Determinant of Response to Chemotherapy through the Regulation of IL-6/STAT3 Pathway in Esophageal Squamous Cell Carcinoma
Keijiro Sugimura et al.
CLINICAL CANCER RESEARCH (2012)
Quercetin abrogates IL-6/STAT3 signaling and inhibits glioblastoma cell line growth and migration
Jonathan Michaud-Levesque et al.
EXPERIMENTAL CELL RESEARCH (2012)
Diet-derived polyphenols inhibit angiogenesis by modulating the interleukin-6/STAT3 pathway
Sylvie Lamy et al.
EXPERIMENTAL CELL RESEARCH (2012)
JAK2 inhibitors in the treatment of myeloproliferative neoplasms
Raoul Tibes et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2012)
(-)-Epigallocatechin Gallate Induces Fas/CD95-Mediated Apoptosis through Inhibiting Constitutive and IL-6-Induced JAK/STAT3 Signaling in Head and Neck Squamous Cell Carcinoma Cells
Hui-Yi Lin et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2012)
Targeting the Interleukin-6/Jak/Stat Pathway in Human Malignancies
Pasquale Sansone et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Targeting Stat3 Induces Senescence in Tumor Cells and Elicits Prophylactic and Therapeutic Immune Responses against Breast Cancer Growth Mediated by NK Cells and CD4+ T Cells
Mercedes Tkach et al.
JOURNAL OF IMMUNOLOGY (2012)
Novel synthetic derivatives of the natural product berbamine inhibit Jak2/Stat3 signaling and induce apoptosis of human melanoma cells
Sangkil Nam et al.
MOLECULAR ONCOLOGY (2012)
Signal transducer and activator of transcription 3 promotes angiogenesis and drives malignant progression in glioma
Tiffany A. Doucette et al.
NEURO-ONCOLOGY (2012)
STAT3 Is Activated by JAK2 Independent of Key Oncogenic Driver Mutations in Non-Small Cell Lung Carcinoma
Brendan D. Looyenga et al.
PLOS ONE (2012)
Curcumin Blocks Small Cell Lung Cancer Cells Migration, Invasion, Angiogenesis, Cell Cycle and Neoplasia through Janus Kinase-STAT3 Signalling Pathway
Cheng-Liang Yang et al.
PLOS ONE (2012)
Orally bioavailable small-molecule inhibitor of transcription factor Stat3 regresses human breast and lung cancer xenografts
Xiaolei Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
JAK2 the future: therapeutic strategies for JAK-dependent malignancies
Lindsay M. LaFave et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2012)
Identification of Antrocin from Antrodia camphorata as a Selective and Novel Class of Small Molecule Inhibitor of Akt/mTOR Signaling in Metastatic Breast Cancer MDA-MB-231 Cells
Yerra Koteswara Rao et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2011)
Perspectives on Sesquiterpene Lactones in Inflammation and Cancer
Irmgard Merfort
CURRENT DRUG TARGETS (2011)
Small Molecule Inhibitors of STAT3 for Cancer Therapy
M. Zhao et al.
CURRENT MEDICINAL CHEMISTRY (2011)
Review of Pharmacological Effects of Antrodia camphorata and Its Bioactive Compounds
Madamanchi Geethangili et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2011)
Overexpression of STAT3 Potentiates Growth, Survival, and Radioresistance of Non-Small-Cell Lung Cancer (NSCLC) cells
Zhen-Jie Yin et al.
JOURNAL OF SURGICAL RESEARCH (2011)
Total Syntheses of Drimane-Type Sesquiterpenoids Enabled by a Gold-Catalyzed Tandem Reaction
Hang Shi et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2011)
Inhibition of JAK2 Signaling by TG101209 Enhances Radiotherapy in Lung Cancer Models
Yunguang Sun et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Knockdown of stat3 expression by RNAi inhibits in vitro growth of human ovarian cancer
Shu-Hua Zhao et al.
RADIOLOGY AND ONCOLOGY (2011)
Dangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancer
Sergei I. Grivennikov et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2010)
Reciprocal Regulation of c-Src and STAT3 in Non-Small Cell Lung Cancer
Lauren Averett Byers et al.
CLINICAL CANCER RESEARCH (2009)
Molecular origins of cancer: Lung cancer
Roy S. Herbst et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Suppression of non-small cell lung tumor development by the let-7 microRNA family
Madhu S. Kumar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The Janus kinase 2 is required for expression and nuclear accumulation of cyclin D1 in proliferating mammary epithelial cells
Kazuhito Sakamoto et al.
MOLECULAR ENDOCRINOLOGY (2007)
Mcl-1, Bcl-XL and Stat3 expression are associated with progression of melanoma whereas Bcl-2, AP-2 and MITF levels decrease during progression of melanoma
Liqing Zhuang et al.
MODERN PATHOLOGY (2007)
Pyridone 6, a pan-janus-activated kinase inhibitor, induces growth inhibition of multiple myeloma cells
Laura Pedranzini et al.
CANCER RESEARCH (2006)
Autocrine IL-6-induced Stat3 activation contributes to the pathogenesis of lung adenocarcinoma and malignant pleural effusion
H-H Yeh et al.
ONCOGENE (2006)
Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity
JZ Sun et al.
ONCOGENE (2005)
Sensitivity of oncogenic KIT mutants to the kinase inhibitors MLN518 and PD180970
AS Corbin et al.
BLOOD (2004)
Combined disruption of both the MEK/ERK and the IL-6R/STAT3 pathways is required to induce apoptosis of multiple myeloma cells in the presence of bone marrow stromal cells
M Chatterjee et al.
BLOOD (2004)
Activation of STAT3 by the Src family kinase Hck requires a functional SH3 domain
SJ Schreiner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
分享论文
